Cookson Peirce & CO Inc Neurocrine Biosciences Inc Transaction History

Cookson Peirce & CO Inc

  • $2.1 Billion
  • Q3 2024

A detailed history of Cookson Peirce & CO Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 2,017 shares of NBIX stock, worth $253,436. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,017
Previous 15,054 86.6%
Holding current value
$253,436
Previous $2.07 Million 88.8%
% of portfolio
0.01%
Previous 0.1%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$114.58 - $153.15 $1.49 Million - $2 Million
-13,037 Reduced 86.6%
2,017 $232,000
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $8,767 - $9,593
-67 Reduced 0.44%
15,054 $2.07 Million
Q1 2024

Apr 23, 2024
BUY
$130.4 - $143.74 $512,732 - $565,185
3,932 Added 35.14%
15,121 $2.09 Million
Q4 2023

Jan 30, 2024
SELL
$106.07 - $132.76 $32,351 - $40,491
-305 Reduced 2.65%
11,189 $1.47 Million
Q3 2023

Nov 07, 2023
BUY
$94.02 - $117.1 $1.08 Million - $1.35 Million
11,494 New
11,494 $1.29 Million
Q4 2022

Jan 31, 2023
SELL
$106.72 - $127.06 $40,446 - $48,155
-379 Reduced 3.32%
11,025 $1.32 Million
Q3 2022

Nov 08, 2022
BUY
$92.03 - $107.81 $1.05 Million - $1.23 Million
11,404 New
11,404 $1.21 Million
Q1 2020

May 04, 2020
SELL
$75.11 - $113.76 $903,047 - $1.37 Million
-12,023 Closed
0 $0
Q4 2019

Jan 27, 2020
BUY
$86.8 - $118.57 $537,552 - $734,304
6,193 Added 106.23%
12,023 $1.29 Million
Q3 2019

Nov 05, 2019
BUY
$83.82 - $101.5 $488,670 - $591,745
5,830 New
5,830 $525,000

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email